CYP1A2 and hepatocellular carcinoma: The next step was to verify whether IP6 has the same effect in HepG2, a commonly used hepatoma cell line, considering that HepG2 has a different expression profile compared to hepatocytes, with an undetectable expression of the CYP1A2 gene [31].